LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,707,000 | -20.1% | 17,903 | -6.3% | 0.09% | -19.8% |
| Q2 2020 | $2,137,000 | +42.7% | 19,107 | -7.3% | 0.12% | +27.5% |
| Q1 2020 | $1,498,000 | -13.4% | 20,605 | +24.3% | 0.09% | +9.6% |
| Q4 2019 | $1,729,000 | -3.1% | 16,575 | -7.5% | 0.08% | -7.8% |
| Q3 2019 | $1,784,000 | -13.6% | 17,925 | -0.9% | 0.09% | -11.8% |
| Q2 2019 | $2,065,000 | +0.5% | 18,092 | +10.7% | 0.10% | +5.2% |
| Q1 2019 | $2,055,000 | +21.9% | 16,348 | +31.6% | 0.10% | +12.8% |
| Q4 2018 | $1,686,000 | -45.4% | 12,427 | +10.5% | 0.09% | -31.7% |
| Q3 2018 | $3,087,000 | +12.8% | 11,247 | -14.8% | 0.13% | +5.0% |
| Q2 2018 | $2,736,000 | -1.2% | 13,206 | -21.2% | 0.12% | -4.0% |
| Q1 2018 | $2,769,000 | +10.7% | 16,768 | -8.2% | 0.12% | +14.7% |
| Q4 2017 | $2,502,000 | -2.6% | 18,275 | -3.2% | 0.11% | -7.6% |
| Q3 2017 | $2,570,000 | +10.9% | 18,878 | -1.1% | 0.12% | +8.3% |
| Q2 2017 | $2,318,000 | +17.5% | 19,091 | +2.4% | 0.11% | +18.5% |
| Q1 2017 | $1,973,000 | +6.1% | 18,643 | +1.9% | 0.09% | +4.5% |
| Q4 2016 | $1,859,000 | +2.9% | 18,298 | +3.4% | 0.09% | +1.1% |
| Q3 2016 | $1,807,000 | -12.5% | 17,703 | +2.2% | 0.09% | -5.4% |
| Q2 2016 | $2,066,000 | +26.4% | 17,320 | +13.5% | 0.09% | +24.3% |
| Q1 2016 | $1,635,000 | -5.0% | 15,264 | +786.9% | 0.07% | -11.9% |
| Q4 2015 | $1,721,000 | +17.2% | 1,721 | -90.0% | 0.08% | +21.7% |
| Q3 2015 | $1,468,000 | -30.0% | 17,142 | -17.6% | 0.07% | -29.6% |
| Q2 2015 | $2,098,000 | +54.0% | 20,793 | +17.7% | 0.10% | +48.5% |
| Q1 2015 | $1,362,000 | +46.6% | 17,668 | +1.2% | 0.07% | +73.7% |
| Q4 2014 | $929,000 | +18.8% | 17,456 | +4.9% | 0.04% | -15.6% |
| Q3 2014 | $782,000 | -7.7% | 16,643 | +22.5% | 0.04% | -10.0% |
| Q2 2014 | $847,000 | -6.5% | 13,590 | +0.9% | 0.05% | -12.3% |
| Q1 2014 | $906,000 | – | 13,464 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |